Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-16 Purchase |
2021-12-20 4:02 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
13,000 | $3.2192 | $41,850 | 909,773 (Indirect Direct) |
View |
| 2021-10-22 Purchase(A) |
2021-12-17 4:18 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
10,000 | $5 | $50,000 | 896,781 (Indirect Direct) |
View |
| 2021-10-22 Purchase |
2021-10-25 5:30 pm |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
3,000 | $5 | $15,000 | 3,000 (Direct) |
View |
| 2021-10-22 Purchase |
2021-10-25 5:30 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
10,000 | $5 | $50,000 | 949,461 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-02 Option Award |
2022-06-03 4:10 pm |
N/A 2032-06-01 |
Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:09 pm |
N/A 2032-06-01 |
Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:09 pm |
N/A 2032-06-01 |
Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-25 4:43 pm |
N/A 2032-02-24 |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
107,870 | $0 | 107,870 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-25 4:42 pm |
N/A 2032-02-24 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
112,470 | $0 | 112,470 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-25 4:38 pm |
N/A 2032-02-24 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
254,300 | $0 | 254,300 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:56 pm |
N/A 2032-02-14 |
Context Therapeutics Inc. | CNTX | Dick Evan G. Former Section 16 officer |
29,223 | $0 | 29,223 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:48 pm |
N/A 2032-02-14 |
Context Therapeutics Inc. | CNTX | Rencher William F. Former Section 16 officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2021-10-22 Exercise(A) |
2021-12-17 4:18 pm |
2020-12-20 2030-12-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $0 | 896,781 (Indirect) |
View |
| 2021-10-22 Conversion(A) |
2021-12-17 4:18 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
797,190 | $0 | 896,781 (Indirect) |
View |
| 2021-10-22 Exercise(A) |
2021-12-17 4:18 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $7.14 | 896,781 (Indirect) |
View |
| 2021-10-22 Conversion(A) |
2021-12-17 4:12 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D |
26,587 | $0 | 82,960 (Direct) |
View |
Ownership(A) |
2021-12-17 4:10 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D |
0 | $0 | 56,373 (Direct) |
View |
Ownership(A) |
2021-12-17 4:08 pm |
N/A 2028-08-27 |
Context Therapeutics Inc. | CNTX | Rencher William F. Head of CMC and Regulatory |
0 | $0 | 416 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-01 4:31 pm |
N/A 2031-11-01 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
52,753 | $0 | 52,753 (Direct) |
View |
| 2021-10-22 Exercise |
2021-10-25 5:30 pm |
2020-12-20 2030-12-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $0 | 949,461 (Indirect) |
View |
| 2021-10-22 Conversion |
2021-10-25 5:30 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
797,198 | $0 | 949,461 (Indirect) |
View |
| 2021-10-22 Exercise |
2021-10-25 5:30 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
52,680 | $7.14 | 949,461 (Indirect) |
View |
| 2021-10-22 Conversion |
2021-10-25 5:29 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D |
26,587 | $0 | 87,139 (Direct) |
View |
Ownership |
2021-10-19 6:11 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
0 | $0 | 1,220,815 (Direct) |
View |
Ownership |
2021-10-19 6:08 pm |
N/A 2031-04-30 |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
0 | $0 | 53,587 (Direct) |
View |
Ownership |
2021-10-19 6:04 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Rencher William F. Head of CMC and Regulatory |
0 | $0 | 13,999 (Direct) |
View |
Ownership |
2021-10-19 6:03 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D |
0 | $0 | 88,389 (Direct) |
View |
Ownership |
2021-10-19 5:59 pm |
N/A 2031-04-30 |
Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-10-19 5:59 pm |
N/A 2031-04-30 |
Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director |
0 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-10-19 5:56 pm |
N/A N/A |
Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director |
0 | $0 | 18,533 (Direct) |
View |
Ownership |
2021-10-19 5:47 pm |
N/A 2031-04-30 |
Context Therapeutics Inc. | CNTX | West Linda Director |
0 | $0 | 15,000 (Direct) |
View |